Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 166.48

+0.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Curtis E. Bemis who wrote (208)	1/24/2000 2:07:00 PM
From: JMarcus	Read Replies (2) of 395

The recent uptick in RGEN's stock I attribute to four factors: 1) Most of the microcap biotechs seems to be sizzling this month, so why not RGEN? At $5/share, the market cap is just $111.6M. Investors are snapping up these low-priced bargains with promising technology. 2) Rosenwald just keeps on buying. The biotech sector is getting so much more attention these days. Many newcomers have no background in biotech, so one of the standard parameters they look for in evaluating biotech stocks is insider buying. Rosenwald's persistent buying catches their attention. 3) The initial gloom about the third party press release concerning its secretin studies has worn off. 4) Most of the excitement on the Yahoo! thread is about ctla-4lg for GvHD. See, for example, messages.yahoo.com Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next